Valuation conundrum of healthcare-related stocks in US and M’sia

THE United States, which is the epicentre of the Covid-19 pandemic, is the base for some of the world’s largest healthcare companies. These companies are in the race to find a vaccine for the virus and have from time to time disclosed the progress of finding a wonder drug to prevent the spread of the virus.

However, the valuations of the more established pharmaceutical companies have remained sober even though the companies are in the forefront of the search to find a vaccine.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Business News

KLCCP Stapled Group records higher 1Q net profit of RM180.56mil
Southern Cable wins RM44.8mil contract from TM
Eversendai returns to the black in 1Q
Leon Fuat optimistic about 2023 performance
Boustead records 1Q net loss of RM62.80mil
Allianz 1Q net profit rises to RM172.69mil
Mida: Malaysia attracts RM71.4bil in approved investments for 1Q
Ringgit ends lower versus greenback on oil price decline, expectation of US rate hike
IJM expects better results in FY24
PNB appoints Raja Arshad as group chairman

Others Also Read